Digestive Diseases Department, Lozano Blesa University Hospital, Zaragoza, Spain.
Aragón Health Research Institute (IIS Aragón), Zaragoza, Spain.
Transpl Int. 2022 May 9;35:10263. doi: 10.3389/ti.2022.10263. eCollection 2022.
In the last few years, several studies have analyzed sex and gender differences in liver transplantation (LT), but none have performed a disaggregated analysis of both mortality and causes of death. Data from 15,998 patients, 11,914 (74.5%) males and 4,069 (25.5%) females, transplanted between 2000 and 2016 were obtained from the Liver Transplantation Spanish Registry. Survival analysis was applied to explore recipient sex as a risk factor for death. The causes of death at different follow-up duration were disaggregated by recipient sex for analysis. Short-term survival was higher in males, whereas long-term survival was higher in females. Survival at 1, 5 and 10 years post-transplant was 87.43%, 73.83%, and 61.23%, respectively, in males and 86.28%, 74.19%, and 65.10%, respectively, in females ( = 0.05). Post-LT mortality related to previous liver disease also presented sex differences. Males had 37% increased overall mortality from acute liver failure ( = 0.035) and 37% from HCV-negative cirrhosis ( < 0.001). Females had approximately 16% increased mortality when the liver disease was HCV-positive cirrhosis ( = 0.003). Regarding causes of death, non-malignancy HCV+ recurrence (6.3% vs. 3.9% of patients; < 0.001), was more frequently reported in females. By contrast, death because of malignancy recurrence (3.9% vs. 2.2% of patients; = 0.003) and malignancy (4.8% vs. 2.5% of patients; < 0.001) were significantly more frequent in male recipients. Cardiovascular disease, renal failure, and surgical complications were similar in both. In summary, male patients have lower short-term mortality than females but higher long-term and overall mortality. In addition, the post-LT mortality risk related to previous liver disease and the causes of mortality differ between males and females.
在过去的几年中,已有多项研究分析了肝移植(LT)中的性别差异,但均未对死亡率和死因进行细分分析。该研究从 2000 年至 2016 年间接受肝移植的 15998 名患者中(11914 名男性,4069 名女性)获得数据,这些数据来自西班牙肝移植登记处。采用生存分析探讨了受体性别作为死亡风险因素。按受体性别对不同随访时间的死亡原因进行细分分析。男性的短期生存率较高,而女性的长期生存率较高。男性患者在移植后 1、5 和 10 年的生存率分别为 87.43%、73.83%和 61.23%,女性患者的生存率分别为 86.28%、74.19%和 65.10%(=0.05)。与既往肝病相关的 LT 后死亡率也存在性别差异。男性急性肝衰竭的总死亡率增加了 37%(=0.035),丙型肝炎阴性肝硬化的死亡率增加了 37%(<0.001)。丙型肝炎阳性肝硬化患者的死亡率增加了约 16%(=0.003)。在死因方面,非恶性 HCV+复发(6.3%与 3.9%的患者;<0.001)在女性中更为常见。相比之下,恶性肿瘤复发(3.9%与 2.2%的患者;=0.003)和恶性肿瘤(4.8%与 2.5%的患者;<0.001)的死亡率在男性患者中明显更高。心血管疾病、肾衰竭和手术并发症在两性中相似。总之,男性患者的短期死亡率低于女性,但长期和总体死亡率较高。此外,与既往肝病相关的 LT 后死亡率风险以及男性和女性的死亡率原因不同。